Alternatively activated macrophages boost induced regulatory T and Th17 cell responses during immunotherapy for colitis

Journal of Immunology

Volumn 196, Issue 8, 2016, Pages 3305-3317

  Haribhai, Dipica ^a   Ziegelbauer, Jennifer ^a   Jia, Shuang ^a   Upchurch, Kyle ^a,c   Yan, Ke ^a   Schmitt, Erica G ^a,d   Salzman, Nita H ^a   Simpson, Pippa ^a   Hessner, Martin J ^a   Chatila, Talal A ^b   Williams, Calvin B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Hospira Inc   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RB ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; COLITIS; CONTROLLED STUDY; FEMALE; IMMUNOTHERAPY; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFER; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STRAIN DIFFERENCE; TH17 CELL; ADOPTIVE IMMUNOTHERAPY; ANIMAL; C57BL MOUSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MOUSE; PROCEDURES; TRANSPLANTATION;

ANIMALS; COLITIS; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-13; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84974839190     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501956     Document Type: Article

References (45)

1. Haribhai, D., J. B. Williams, S. Jia, D. Nickerson, E. G. Schmitt, B. Edwards, J. Ziegelbauer, M. Yassai, S. H. Li, L. M. Relland, et al. 2011. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 35: 109-122.
2. Josefowicz, S. Z., R. E. Niec, H. Y. Kim, P. Treuting, T. Chinen, Y. Zheng, D. T. Umetsu, and A. Y. Rudensky. 2012. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482: 395-399.
3. Haribhai, D., W. Lin, B. Edwards, J. Ziegelbauer, N. H. Salzman, M. R. Carlson, S. H. Li, P. M. Simpson, T. A. Chatila, and C. B. Williams. 2009. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J. Immunol. 182: 3461-3468.
4. Schmitt, E. G., D. Haribhai, J. B. Williams, P. Aggarwal, S. Jia, L. M. Charbonnier, K. Yan, R. Lorier, A. Turner, J. Ziegelbauer, et al. 2012. IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. J. Immunol. 189: 5638-5648.
5. Hsieh, C. S., Y. Liang, A. J. Tyznik, S. G. Self, D. Liggitt, and A. Y. Rudensky. 2004. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21: 267-277.
6. Lathrop, S. K., S. M. Bloom, S. M. Rao, K. Nutsch, C. W. Lio, N. Santacruz, D. A. Peterson, T. S. Stappenbeck, and C. S. Hsieh. 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478: 250-254.
7. Relland, L. M., J. B. Williams, G. N. Relland, D. Haribhai, J. Ziegelbauer, M. Yassai, J. Gorski, and C. B. Williams. 2012. The TCR repertoires of regulatory and conventional T cells specific for the same foreign antigen are distinct. J. Immunol. 189: 3566-3574.
8. Shih, F. F., L. Mandik-Nayak, B. T. Wipke, and P. M. Allen. 2004. Massive thymic deletion results in systemic autoimmunity through elimination of CD4+ CD25+ T regulatory cells. J. Exp. Med. 199: 323-335.
9. Bilate, A. M., and J. J. Lafaille. 2012. Induced CD4+Foxp3+ regulatory T cells in immune tolerance. Annu. Rev. Immunol. 30: 733-758.
10. Quintana, F. J., A. S. Basso, A. H. Iglesias, T. Korn, M. F. Farez, E. Bettelli, M. Caccamo, M. Oukka, and H. L. Weiner. 2008. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71.
11. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
12. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-b and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
13. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199: 1401-1408.
14. Curotto de Lafaille, M. A., A. C. Lino, N. Kutchukhidze, and J. J. Lafaille. 2004. CD252 T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268.
15. Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J. J. Lafaille, and M. A. Curotto de Lafaille. 2005. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115: 1923-1933.
16. Beres, A., R. Komorowski, M. Mihara, and W. R. Drobyski. 2011. Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease. Clin. Cancer Res. 17: 3969-3983.
17. Floess, S., J. Freyer, C. Siewert, U. Baron, S. Olek, J. Polansky, K. Schlawe, H. D. Chang, T. Bopp, E. Schmitt, et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5: e38.
18. Shull, M. M. I., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
19. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor b1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774.
20. Ramalingam, R., C. B. Larmonier, R. D. Thurston, M. T. Midura-Kiela, S. G. Zheng, F. K. Ghishan, and P. R. Kiela. 2012. Dendritic cell-specific disruption of TGF-b receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity. J. Immunol. 189: 3878-3893.
21. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. TH-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
22. Lee, Y., A. Awasthi, N. Yosef, F. J. Quintana, S. Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D. A. Hafler, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13: 991-999.
23. Denning, T. L., Y. C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8: 1086-1094.
24. Murai, M., O. Turovskaya, G. Kim, R. Madan, C. L. Karp, H. Cheroutre, and M. Kronenberg. 2009. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10: 1178-1184.
25. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
26. Mills, C. D., K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164: 6166-6173.
27. Lin, W., D. Haribhai, L. M. Relland, N. Truong, M. R. Carlson, C. B. Williams, and T. A. Chatila. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8: 359-368.
28. Leach, M. W., A. G. Bean, S. Mauze, R. L. Coffman, and F. Powrie. 1996. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am. J. Pathol. 148: 1503-1515.
29. Gentleman, R. C., V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, et al. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5: R80.
30. Hong, F., R. Breitling, C. W. McEntee, B. S. Wittner, J. L. Nemhauser, and J. Chory. 2006. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827.
31. Edgar, R., M. Domrachev, and A. E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210.
32. Salzman, N. H., K. Hung, D. Haribhai, H. Chu, J. Karlsson-Sjöberg, E. Amir, P. Teggatz, M. Barman, M. Hayward, D. Eastwood, et al. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11: 76-83.
33. Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787-795.
34. Takaki, H., K. Ichiyama, K. Koga, T. Chinen, G. Takaesu, Y. Sugiyama, S. Kato, A. Yoshimura, and T. Kobayashi. 2008. STAT6 Inhibits TGF-b1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J. Biol. Chem. 283: 14955-14962.
35. Dardalhon, V., A. Awasthi, H. Kwon, G. Galileos, W. Gao, R. A. Sobel, M. Mitsdoerffer, T. B. Strom, W. Elyaman, I. C. Ho, et al. 2008. IL-4 inhibits TGF-b-induced Foxp3+ T cells and, together with TGF-b, generates IL-9+ IL-10+ Foxp32 effector T cells. Nat. Immunol. 9: 1347-1355.
36. Cooney, L. A., K. Towery, J. Endres, and D. A. Fox. 2011. Sensitivity and resistance to regulation by IL-4 during Th17 maturation. J. Immunol. 187: 4440-4450.
37. Yu, F., S. Sharma, J. Edwards, L. Feigenbaum, and J. Zhu. 2015. Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat. Immunol. 16: 197-206.
38. Wang, Y., M. A. Su, and Y. Y. Wan. 2011. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35: 337-348.
39. Wohlfert, E. A., J. R. Grainger, N. Bouladoux, J. E. Konkel, G. Oldenhove, C. H. Ribeiro, J. A. Hall, R. Yagi, S. Naik, R. Bhairavabhotla, et al. 2011. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121: 4503-4515.
40. Heylen, M., N. E. Ruyssers, E. M. Gielis, E. Vanhomwegen, P. A. Pelckmans, T. G. Moreels, J. G. De Man, and B. Y. De Winter. 2014. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease. Pharmacol. Ther. 143: 153-167.
41. Durant, L., W. T. Watford, H. L. Ramos, A. Laurence, G. Vahedi, L. Wei, H. Takahashi, H. W. Sun, Y. Kanno, F. Powrie, and J. J. O'Shea. 2010. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32: 605-615.
42. Yang, X. P., K. Ghoreschi, S. M. Steward-Tharp, J. Rodriguez-Canales, J. Zhu, J. R. Grainger, K. Hirahara, H. W. Sun, L. Wei, G. Vahedi, et al. 2011. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12: 247-254.
43. Burchill, M. A., J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar. 2007. IL-2 receptor b-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178: 280-290.
44. Xu, L., A. Kitani, C. Stuelten, G. McGrady, I. Fuss, and W. Strober. 2010. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33: 313-325.
45. Esplugues, E., S. Huber, N. Gagliani, A. E. Hauser, T. Town, Y. Y. Wan, W. O'Connor, Jr., A. Rongvaux, N. Van Rooijen, A. M. Haberman, et al. 2011. Control of TH17 cells occurs in the small intestine. Nature 475: 514-518.